Skip to main content

Table 2 4D flow CMR studies in valvular heart disease

From: Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review

Valve pathology

Study

Nr of patients (n)

Population assessed

Reproducibility assessment

4D Flow CMR vs. TTE

4D Flow CMR vs. PCMR

Main findings

Mitral regurgitation

2008 Westenberg et al. [69]

Controls n = 10

Patients n = 20

Ischaemic cardiomyopathy with mitral regurgitation and/or TR

+ 

−

+ 

PCMR overestimated transmitral flow in healthy volunteers

4D Flow CMR showed strong agreement between MV and TV flow in patients with mitral regurgitation and/or TR

2009 Roes et al. [25]

Controls n = 22

Patients n = 29

Ischaemic cardiomyopathy with valvular regurgitation

+ 

−

−

Agreement amongst net flow volume for all valves was excellent

Good intra- and inter-observer reliability for quantification of RF

2009 Marsan et al. [72]

Patients n = 64

Functional mitral regurgitation

−

+ (3D TTE)

−

2D TTE significantly underestimated mitral regurgitation

2011 Brandts et al. [71]

Patients n = 47

Ischaemic heart failure

−

+ 

+ 

Higher mitral regurgitant fraction vs. PCMR

Strong correlation between 4D Flow CMR and TTE for LV diastolic assessment

2018 Gorodisky et al. [74]

Patients n = 27

Isolated mitral regurgitation of various severity

+ 

+ 

+ 

CMR 4D-PISA was feasible

CMR 4D-PISA was smaller than TTE-PISA

2018 Feneis et al. [9]

Patients n = 21

Isolated mitral regurgitation n = 10

Mitral regurgitation + TR n = 5

Isolated TR = 6

+ 

−

+ 

Good correlation between PCMR and 4D Flow CMR quantification of regurgitation by direct and indirect methods

2019 Kamphuis et al. [70]

Controls = 46

Patients n = 114

Acquired and congenital pathologies

 + 

−

−

Automated valve tracking is performed more rapidly than manual valve tracking

Strong intra- and inter-observer correlation for regurgitant fraction quantification by automated valve tracking

2020 Blanken et al. [73]

Patients n = 30

Various degrees of mitral regurgitation severity

 + 

−

+ 

Valve tracking underestimated mitral regurgitation severity in cases of severe mitral regurgitation

SFT RV correlated better with indirect quantification of RV by PCMR than RVT

2021 Fidock et al. [54]

Patients n = 35

Primary mitral regurgitation n = 12

Secondary mitral regurgitation n = 10

MVR n = 13

+ 

−

+ 

Highest reproducibility was found for MV inflow-AV outflow method of mitral regurgitation quantification

Good correlation between all methods in secondary mitral regurgitation and MVR

2021 Spampinato et al. [42]

Controls = 6

Patients = 54

Mitral valve prolapse

+ 

+ 

+ 

Indirect 4D Flow CMR assessment of mitral regurgitation in MVP showed better intra- and inter-technique concordance than direct assessment

2021 Juffermans et al. [26]

Patients n = 64

Controls n = 76

Various pathologies

 + 

−

−

Strong-to-excellent interobserver reliability for forward flow volume and net forward volume for all valves

Moderate-to-excellent reliability for assessment of RF for all valves

Aortic regurgitation

2013 Ewe et al. [86]

Patients n = 32

Various degrees of AR severity

−

+ (3D TTE)

−

High concordance between 3D-TTE and 4D Flow CMR

2016 Chelu et al. [85]

Patients n = 54

Various pathologies

−

+ 

−

AR severity by 4D Flow CMR correlated well with TTE

2020 Alvarez et al. [79]

Patients n = 34

AR > 5%

−

−

+ 

AV forward and regurgitant flow by 4D Flow CMR agreed well with PCMR

2021 Juffermans et al. [26]

Patients = 64

Controls = 76

Various pathologies

+ 

−

−

Strong-to-excellent interobserver reliability for forward flow volume and net forward volume for all valves

Moderate-to-excellent reliability for assessment of RF for all valves

Aortic Stenosis

2013 Dyverfeldt et al. [93]

Controls n = 4

Patients n = 14

Aortic dilatation present in some cases

−

+ 

−

Patients with AS demonstrated much higher peak total TKE in the ascending aorta

2014 Garcia et al. [90]

Controls n = 10

Patients n = 40

Tricuspid and bicuspid AS

+ 

−

+ 

EOA measurement by 4D Flow CMR jet shear layer detection method was feasible

3D projection of vena contracta by 4D Flow CMR enabled more accurate localisation of the measurement plane

2016 Negahdar et al. [92]

Controls n = 5

Patients n = 4

 ≤ moderate AS

−

 + 

−

Spiral 4D Flow readout resulted in shorter TE and shorter scan time

2020 Archer et al. [91]

Patients n = 18

SAVR n = 10

TAVR n = 8

−

 + 

−

Invasive peak pressure gradient and4D Flow CMR derived peak pressure gradient correlated well

Prognostic advantage of 4D Flow CMR derived gradient vs. TTE

2020 Callahan et al. [37]

Controls n = 6

Patients n = 8

Severe aortic stenosis

−

−

−

Combination of dual-VENC 4D Flow acquisition and spiral read-out offers increased velocity resolution and reduced scan time

Bicuspid aortic valve

2018 Bissell et al. [34]

Controls n = 30

Patients n = 60

Native BAV n = 30

Prior AVR n = 30

−

−

−

Normalisation of wall shear stress and rotational flow in patients with mechanical AVR or Ross procedure, but not those with bioprosthetic AV

2019 Elbaz et al. [98]

Controls n = 34

Patients n = 57

BAV; stenotic and regurgitant valves

 + 

−

−

Kinetic energy, viscous energy loss rate and vorticity were reproducible in BAV patients

Patients with severe AS showed highest levels of VELR and vorticity

2019 Dux-Santoy et al. [96]

Controls n = 24

Patients n = 132

BAV n = 111; non-severe disease

TAV with dilated arch n = 21

−

−

−

In-plane rotational flow, right/noncoronary BAV and systolic flow reversal ratio were predictors of aortic dilatation

2020 Fatehi Hassanabad et al. [99]

Controls n = 11

Patients n = 32

BAV; stenotic and regurgitant valves

 + 

−

 + 

Larger pressure drop was observed in patients with > than moderate BAV stenosis

Tricuspid regurgitation

2008 Westenberg et al. [69]

Controls n = 10

Patients n = 20

Ischaemic cardiomyopathy with mitral regurgitation and/or TR

 + 

−

 + 

PCMR overestimated transtricuspid flow

4D Flow CMR showed strong agreement between MV and TV flow in patients with mitral regurgiatiton and/or TR

2009 Roes et al. [25]

Controls n = 22

Patients n = 29

Ischaemic cardiomyopathy with valvular regurgitation

 + 

−

−

Agreement amongst net flow volume for all valves was excellent

Good intra- and interobserver reliability for quantification of RF

2018 Feneis et al. [9]

Patients n = 21

Isolated TR n = 6

Mitral regurgitation + TR n = 5

Isolated mitral regurgitaiton n = 10

 + 

−

 + 

Good correlation between PCMR and 4D Flow CMR quantification of regurgitation by direct and indirect methods

2018 Driessen et al. [100]

Controls n = 21

Patients n = 67

RV pressure overload

+ 

+ 

+ 

Excellent concordance of effective TV flow vs. PCMR derived effective PV flow

4D Flow reclassified TR severity to a different grade vs. TTE grades

2021 Juffermans et al. [26]

Patients = 64

Controls = 76

Various pathologies

+ 

−

−

Strong-to-excellent interobserver reliability for forward flow volume and net forward volume for all valves

Moderate-to-excellent reliability for assessment of RF for all valves

Pulmonary regurgitation

2016 Chelu et al. [101]

Patients n = 52

Heterogenous group

+ 

−

+ 

Peak systolic PV velocity may be underestimated; this can be minimised by measuring the velocity where it appears to be the highest

2019 Rizk et al. [103]

Controls n = 11

Patients n = 49

Tetralogy of Fallot n = 30

BAV n = 19

+ 

−

−

Severity of PR was proportional to peak diastolic WSS

2020 Jacobs et al. [102]

Patients n = 34

Paediatric patients with repaired Tetralogy of Fallot

+ 

−

+ 

Pulmonary flow and aortic flow were most consistent at valve level

RV ejection fraction was more reproducible by 4D Flow CMR vs. standard CMR

RV volumes were mildly overestimated by 4D Flow CMR

2021 Juffermans et al. [26]

Patients = 64

Controls = 76

Various pathologies

+ 

−

−

Strong-to-excellent interobserver reliability for forward flow volume and net forward volume for all valves

Moderate-to-excellent reliability for assessment of RF for all valves

  1. AR = aortic regurgitation; AS = aortic stenosis; AV = aortic valve; AVR = aortic valve replacement; BAV = bicuspid aortic valve; CHD = congenital heart disease; CMR = cardiovascular magnetic resonance; EROA = effective regurgitant orifice area; KE = kinetic energy; LV = left ventricle; LVEF = left ventricular ejection fraction; MV = mitral valve; MVR = mitral valve replacement; PCMR = phase contrast magnetic resonance; PISA = proximal isovelocity surface area; PR = pulmonary regurgitation; PV = pulmonary valve; RF = regurgitant fraction; RVol = regurgitant volume; RV = right ventricle; RVT = retrospective valve tracking; SAVR = surgical aortic valve replacement; SFT = semi-automated flow tracking; TAV = tricuspid aortic valve; TAVR = transcatheter aortic valve replacement; TKE = turbulent kinetic energy; TR = tricuspid regurgitation; TTE = transthoracic echocardiography; TV = tricuspid valve; VELR = viscous energy loss rate; VENC = velocity encoding; WSS = wall shear stress